Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/12/25 18:34 | 6/10/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | 3 | S | -4,346 | 44.42 | 0 | -98 | 624 | D | |||||||||||||||
6/12/25 18:33 | 6/10/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Rolph Timothy | CA | O | Chief Sc | 5 | S.dm | -3,196 | 49.27 | 0 | -65 | 170 | D | |||||||||||||||
6/12/25 18:33 | 6/10/25 | AKRO | Health | Drug | Pharmaceutical Preparations | White William Richard | CA | O | CFO | 1 | S | -151 | 54.00 | 0 | -3 | 59 | D | |||||||||||||||
6/12/25 18:33 | 6/10/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Yale Catriona | CA | O | Chief De | 4 | S.d | -1,336 | 41.91 | 0 | -32 | 95 | D | |||||||||||||||
6/12/25 18:32 | 6/10/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Lamy Patrick | CA | O | SVP,Comm | 4 | S.d | -791 | 46.74 | 0 | -17 | 33 | D | |||||||||||||||
6/12/25 18:32 | 6/10/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | 1 | S | -135 | 53.99 | 0 | -2 | 258 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |